Original Articles

Correlation of serum cardiolipin levels with physical activity in type 2 diabetes mellitus patients

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 18 December 2025
82
Views
71
Downloads
4
HTML

Authors

Cardiolipin, a critical phospholipid involved in mitochondrial function, has a potential role in the pathogenesis of type 2 diabetes mellitus. This research aims to assess serum cardiolipin levels in type 2 diabetic patients and examine their correlation with their physical activity, age, and gender. The study employed cross-sectional research conducted at Lahore Garrison University and Lahore Medical Research Center. Physical activity and serum cardiolipin levels were measured using the International Physical Activity Questionnaire (IPAQ) and a chemical analyzer, respectively. A sample size of 80 participants was analyzed statistically using t-tests and analysis of variance in GraphPad Prism 8.0.2 (263). IPAQ demonstrated that most patients (56%) were of the moderate activity category. Across age groups, there were significant differences in cardiolipin and blood sugar levels. Similarly, important differences were found in serum cardiolipin (p=0.0001), glycated hemoglobin (p=0.0499), and blood sugar (p=0.0021) levels among low, moderate, and vigorous physical activity groups. No significant difference was noticed among genders. Conclusions: Our research highlighted the potential age-dependent impact of physical activity on cardiolipin levels, emphasizing its relevance to mitochondrial health. A significant difference was also found between physical activity and blood sugar.

Downloads

Download data is not yet available.

Citations

Balducci S, Zanuso S, Cardelli P, et al. Effect of high-versus low-intensity supervised aerobic and resistance training on modifiable cardiovascular risk factors in type 2 diabetes; the Italian Diabetes and Exercise Study (IDES). PLoS One 2012;7:e49297.
Bener A, Zirie M, Janahi IM, et al. Prevalence of diagnosed and undiagnosed diabetes mellitus and its risk factors in a population-based study of Qatar. Diabetes Res Clin Pract 2009;84:99-106.
Boniol M, Dragomir M, Autier P, et al. Physical activity and change in fasting glucose and HbA1c: a quantitative meta-analysis of randomized trials. Acta Diabetol 2017;54:983-91.
Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet 2017;389:2239-51.
Chen WW, Chao YJ, Chang WH, et al. Phosphatidylglycerol incorporates into cardiolipin to improve mitochondrial activity and inhibits inflammation. Sci Rep 2018;8:4919.
Paradies G, Paradies V, Ruggiero FM, et al. Role of cardiolipin in mitochondrial function and dynamics in health and disease: molecular and pharmacological aspects. Cells 2019;8:728.
Falabella M, Vernon HJ, Hanna MG, et al. Cardiolipin, mitochondria, and neurological disease. Trends Endocrinol Metab 2021;32:224-37.
Galicia-Garcia U, Benito-Vicente A, Jebari S, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci 2020;21:6275.
Kiebish MA, Han X, Cheng H, et al. Lipidomic analysis and electron transport chain activities in C57BL/6J mouse brain mitochondria. J Neurochem 2008;106:299-312.
Sriram V, Sridhar GR, Madhu K. Gender differences in living with type 2 diabetes. Int J Diab Dev Ctries 2001;21:97-102.
Rao CR, Kamath VG, Shetty A, et al. A study on the prevalence of type 2 diabetes in coastal Karnataka. Int J Diabetes Dev Ctries 2010;30:80.
Mahar SA, Hasan MI, Khan MIH, et al. Comparison of hypoglycaemia episodes in people with type-2 diabetes fasting in Ramazan, treated with vildagliptin or sulphonylurea: results of the Pakistani cohort of the VIRTUE study. J Pak Med Assoc 2014;64:1297-302.
Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010;362:800-11.
Droumaguet C, Balkau B, Simon D, et al. Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2006;29:1619-25.
Ntaios G, Egli M, Faouzi M, et al. J-shaped association between serum glucose and functional outcome in acute ischemic stroke. Stroke 2010;41:2366-70.
Kiebish MA, Bell R, Yang K, et al. Dynamic simulation of cardiolipin remodeling: greasing the wheels for an interpretative approach to lipidomics. J Lipid Res 2010;51:2153-70.
Turnbull FM, Abraira C, Anderson RJ, et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 2009;52:2288-97.
Colberg SR, Sigal RJ, Yardley JE, et al. Physical activity/exercise and diabetes: a position statement of the American Diabetes Association. Diabetes Care 2016;39:2065-79.
Sorriento D, Di Vaia E, Iaccarino G. Physical exercise: a novel tool to protect mitochondrial health. Front Physiol 2021;12:660068.

How to Cite



Correlation of serum cardiolipin levels with physical activity in type 2 diabetes mellitus patients. (2025). Italian Journal of Medicine, 19(4). https://doi.org/10.4081/itjm.2025.2363